Literature DB >> 20499851

Antiviral and anti-inflammatory diterpenoids from the soft coral Sinularia gyrosa.

Shi-Yie Cheng1, Cheng-Ta Chuang, Shang-Kwei Wang, Zhi-Hong Wen, Shu-Fen Chiou, Chi-Hsin Hsu, Chang-Feng Dai, Chang-Yih Duh.   

Abstract

Chemical investigation of the soft coral Sinularia gyrosa led to the purification of three new diterpenoids, designated as gyrosanols A-C (1-3). The structures of 1-3 were elucidated through extensive spectroscopic analyses. Compounds 1 and 2 exhibited antiviral activity against HCMV with IC(50)'s of 2.6 and 3.7 microM, respectively. In addition, compounds 1 and 2 showed significant anti-inflammatory activity by reducing the levels of the COX-2 protein (19.6 + or - 3.9% and 29.1 + or - 9.6%, respectively) in RAW 264.7 macrophages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499851     DOI: 10.1021/np100185a

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  14 in total

1.  A great barrier reef Sinularia sp. yields two new cytotoxic diterpenes.

Authors:  Anthony D Wright; Jonathan L Nielson; Dianne M Tapiolas; Catherine H Liptrot; Cherie A Motti
Journal:  Mar Drugs       Date:  2012-07-31       Impact factor: 6.085

2.  Anti-Inflammatory and Analgesic Effects of the Marine-Derived Compound Excavatolide B Isolated from the Culture-Type Formosan Gorgonian Briareum excavatum.

Authors:  Yen-You Lin; Sung-Chun Lin; Chien-Wei Feng; Pei-Chin Chen; Yin-Di Su; Chi-Min Li; San-Nan Yang; Yen-Hsuan Jean; Ping-Jyun Sung; Chang-Yih Duh; Zhi-Hong Wen
Journal:  Mar Drugs       Date:  2015-04-27       Impact factor: 5.118

Review 3.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

Review 4.  Anti-inflammatory activities of natural products isolated from soft corals of Taiwan between 2008 and 2012.

Authors:  Wen-Chi Wei; Ping-Jyun Sung; Chang-Yih Duh; Bo-Wei Chen; Jyh-Horng Sheu; Ning-Sun Yang
Journal:  Mar Drugs       Date:  2013-10-23       Impact factor: 5.118

5.  A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis.

Authors:  Yen-You Lin; Yen-Hsuan Jean; Hsin-Pai Lee; Wu-Fu Chen; Yu-Min Sun; Jui-Hsin Su; Yi Lu; Shi-Ying Huang; Han-Chun Hung; Ping-Jyun Sung; Jyh-Horng Sheu; Zhi-Hong Wen
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

6.  Inhibition of NF-κB transcriptional activation in HepG2 cells by diterpenoids from the soft coral Sinularia maxima.

Authors:  Nguyen Phuong Thao; Nguyen Hoai Nam; Nguyen Xuan Cuong; Bui Thi Thuy Luyen; Bui Huu Tai; Ji Eun Kim; Seok Bean Song; Phan Van Kiem; Chau Van Minh; Young Ho Kim
Journal:  Arch Pharm Res       Date:  2013-08-10       Impact factor: 4.946

7.  Numerosol A-D, new cembranoid diterpenes from the soft coral Sinularia numerosa.

Authors:  Yen-Ju Tseng; Yuan-Chien Yang; Shang-Kwei Wang; Chang-Yih Duh
Journal:  Mar Drugs       Date:  2014-06-03       Impact factor: 5.118

8.  Bioactive cembrane derivatives from the Indian Ocean soft coral, Sinularia kavarattiensis.

Authors:  Katja-Emilia Lillsunde; Carmen Festa; Harshada Adel; Simona De Marino; Valter Lombardi; Supriya Tilvi; Dorota A Nawrot; Angela Zampella; Lisette D'Souza; Maria Valeria D'Auria; Päivi Tammela
Journal:  Mar Drugs       Date:  2014-07-03       Impact factor: 5.118

Review 9.  Antimicrobials from Cnidarians. A New Perspective for Anti-Infective Therapy?

Authors:  Gian Luigi Mariottini; Irwin Darren Grice
Journal:  Mar Drugs       Date:  2016-03-08       Impact factor: 5.118

10.  Anti-Inflammatory Lobane and Prenyleudesmane Diterpenoids from the Soft Coral Lobophytum varium.

Authors:  Atallah F Ahmed; Wan-Ting Teng; Chiung-Yao Huang; Chang-Feng Dai; Tsong-Long Hwang; Jyh-Horng Sheu
Journal:  Mar Drugs       Date:  2017-09-29       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.